Related Experiment Video
Updated: May 20, 2026
06:54
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Protein phosphatase 5 modulates SMAD3 function in the transforming growth factor-β pathway
David L Bruce1, Thomas Macartney, Weidong Yong
1MRC Protein Phosphorylation Unit, College of Life Sciences, University of Dundee, Dundee, UK.
Cellular Signalling
|July 12, 2012
Summary
Protein phosphatase 5 (PP5) regulates the transforming growth factor-β (TGFβ) pathway by controlling SMAD3 protein levels. PP5-null cells show enhanced TGFβ responses due to increased SMAD3 protein, not altered gene expression.
Area of Science:
- Cellular signaling
- Molecular biology
- Signal transduction
Background:
- Protein phosphatases are crucial for balancing cellular responses to transforming growth factor-β (TGFβ) signaling.
- While PPM1A was thought to dephosphorylate SMAD2/3 in the nucleus, it's found in the cytoplasm, leaving a nuclear phosphatase elusive.
Purpose of the Study:
- To investigate the role of protein phosphatase 5 (PP5) in the TGFβ pathway.
- To identify novel regulators of SMAD proteins within the TGFβ signaling cascade.
Main Methods:
- Interaction studies to identify PP5 as a SMAD2/3 interactor.
- Analysis of TGFβ-induced transcriptional responses in PP5-null mouse embryonic fibroblast (MEF) cells compared to wild-type.
- Assessment of SMAD3 protein and transcript levels in PP5-null and wild-type MEFs.
- In vitro dephosphorylation assays using PP5 and SMAD3.
Main Results:
- PP5 was identified as an interactor of SMAD2/3.
- TGFβ-induced transcriptional responses were significantly enhanced in PP5-null MEFs.
- PP5-null MEFs exhibited increased levels of SMAD3 protein, but not SMAD3 transcripts, compared to wild-type.
- PP5 dephosphorylates SMAD3-tail in vitro and is essential for controlling SMAD3 protein levels in MEFs.
Conclusions:
- Protein phosphatase 5 (PP5) plays a regulatory role in the TGFβ pathway.
- PP5 controls TGFβ signaling by modulating SMAD3 protein levels, not transcript levels.
- The study identifies PP5 as a key regulator of SMAD3 protein stability within the TGFβ pathway.
More Related Videos
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
11:06Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System
Published on: July 30, 2018
Related Concept Videos
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
02:54Protein Kinases and Phosphatases
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
02:54Protein Kinases and Phosphatases
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...